Related references
Note: Only part of the references are listed.Functional Analysis and Transcriptomic Profiling of iPSC-Derived Macrophages and Their Application in Modeling Mendelian Disease
Hanrui Zhang et al.
CIRCULATION RESEARCH (2015)
The challenges of developing effective anti-inflammatory agents in cystic fibrosis
Scott D. Sagel
JOURNAL OF CYSTIC FIBROSIS (2015)
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
Stefania Fiorcari et al.
HAEMATOLOGICA (2015)
Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa
Kenneth P. Tai et al.
INNATE IMMUNITY (2015)
Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
Benjamin J. Staudinger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides
Sibel Dosler et al.
PEPTIDES (2014)
Killing of Staphylococci by θ-Defensins Involves Membrane Impairment and Activation of Autolytic Enzymes
Miriam Wilmes et al.
ANTIBIOTICS-BASEL (2014)
Antimicrobial Peptide GL13K Is Effective in Reducing Biofilms of Pseudomonas aeruginosa
Helmut Hirt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Response of CFTR-Deficient Mice to Long-Term chronic Pseudomonas aeruginosa Infection and PTX3 Therapy
Moira Paroni et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
PmrB Mutations Promote Polymyxin Resistance of Pseudomonas aeruginosa Isolated from Colistin-Treated Cystic Fibrosis Patients
Samuel M. Moskowitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
Arianna Pompilio et al.
BMC MICROBIOLOGY (2012)
θ-Defensins: Cyclic Peptides with Endless Potential
Robert I. Lehrer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis
Justin B. Schaal et al.
PLOS ONE (2012)
Humanized θ-Defensins (Retrocyclins) Enhance Macrophage Performance and Protect Mice from Experimental Anthrax Infections
S. Welkos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients
Amanda K. Miller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms
Rinki Kapoor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities
Prasad Tongaonkar et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Murine models of acute and chronic lung infection with cystic fibrosis pathogens
Alessandra Bragonzi
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Design, assembly, and validation of a nose-only inhalation exposure system for studies of aerosolized viable influenza H5N1 virus in ferrets
Richard S. Tuttle et al.
VIROLOGY JOURNAL (2010)
Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals
David J. Alexander et al.
INHALATION TOXICOLOGY (2008)
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins
Dat Tran et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis
Christian A. Merlo et al.
CHEST (2007)
Diversity of biofilms produced by quorum-sensing-deficient clinical isolates of Pseudomonas aeruginosa
J. Andy Schaber et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa
JB McPhee et al.
MOLECULAR MICROBIOLOGY (2003)
Evolution of primate theta-defensins: a serpentine path to a sweet tooth
TX Nguyen et al.
PEPTIDES (2003)
Murine models of chronic Pseudomonas aeruginosa lung infection
AM van Heeckeren et al.
LABORATORY ANIMALS (2002)
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
J Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically
A Giacometti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Engineered salt-insensitive α-defensins with end-to-end circularized structures
QT Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)